Clinical trial
An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
NCT03476317 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 12, 2018
- Completion date
- December 31, 2020
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.